Digitalization and AI in pharmaceutical industrial sites — from discussion to action

The roundtable, organized by ManageArt and featuring the participation of managers from various pharmaceutical plants and areas involved in real projects, will provide a practical and realistic view of how digitalization and artificial intelligence are transforming pharmaceutical industrial plants: what is being done, where the real opportunities lie, what barriers and resistances exist, the different implementation approaches, and the returns being achieved.

Through the exchange of experiences among the key actors involved in these projects, the discussion will address the factors that determine their success: the criteria guiding investment decisions, the enablers that facilitate implementation, the most common internal barriers and resistances, and the organizational impact associated with these initiatives.

The session will also cover specific aspects of the pharmaceutical regulatory environment, including the validation of AI-based systems, experiences with audits by regulatory authorities, and expectations regarding Annex 22 of GMP.

A session designed to contrast real, first-hand experiences with professionals facing the same challenges.